Epidemiology of HER2-low breast cancer in Lithuania

被引：0
|
作者：
Cesas, A. [1 ]
Poskiene, L. [2 ]
Valkiuniene, R. B. [3 ]
Radvinskiene, L. [4 ]
Lege, I. [5 ]
机构：
[1] Klaipeda Univ Hosp, Dept Oncol, Klaipeda, Lithuania
[2] Lithuanian Univ Hlth Sci, Dept Pathol, Kaunas, Lithuania
[3] Natl Ctr Pathol, Dept Breast Pathol, Vilnius, Lithuania
[4] Klaipeda Univ Hosp, Dept Pathol, Klaipeda, Lithuania
[5] AstraZeneca, Balt Med & Regulatory Dept, Vilnius, Lithuania
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113843
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
276 (PB-09
引用
收藏
页码：103 / 104
页数：2
相关论文
共 50 条
  • [21] HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Altena, Renske
    af Buren, Siri
    Tran, Thuy
    Axelsson, Rimma
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1842 - 1842
  • [22] HER2-low breast cancer: a new concept in breast cancer treatment strategy
    Deluche, Elise
    Vincent-Salomon, Anne
    BULLETIN DU CANCER, 2021, 108 (11) : S1 - S7
  • [23] The clinicopathological and prognostic significance of HER2-low breast cancer: A comparative analysis between HER2-low and HER2-zero subtypes
    Nishimura, Reiki
    Fujiki, Yoshitaka
    Taira, Tetsuhiko
    Miyaki, Toshiko
    Kanemitsu, Shuichi
    Yotsumoto, Daisuke
    Teraoka, Megumi
    Kawano, Junko
    Gondo, Naomi
    Mitsueda, Reiko
    Baba, Shinichi
    Ohi, Yasuyo
    Rai, Yoshiaki
    Sagara, Yoshiaki
    Sagara, Yasuaki
    CANCER RESEARCH, 2024, 84 (09)
  • [24] HER2-low breast cancer: Evolution from primary breast cancer to relapse
    Miglietta, F.
    Griguolo, G.
    Bottosso, M.
    Giarratano, T.
    Lo Mele, M.
    Fassan, M.
    Cacciatore, M.
    Genovesi, E.
    De Bartolo, D.
    Vernaci, G.
    Conte, P. F.
    Guarneri, V.
    Dieci, M. V.
    ANNALS OF ONCOLOGY, 2021, 32 : S23 - S23
  • [25] The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes
    Nishimura, Reiki
    Fujiki, Yoshitaka
    Taira, Tetsuhiko
    Miyaki, Toshiko
    Kanemitsu, Shuichi
    Yotsumoto, Daisuke
    Teraoka, Megumi
    Kawano, Junko
    Gondo, Naomi
    Mitsueda, Reiko
    Baba, Shinichi
    Ohi, Yasuyo
    Rai, Yoshiaki
    Sagara, Yoshiaki
    Sagara, Yasuaki
    CLINICAL BREAST CANCER, 2024, 24 (05) : 431 - 438
  • [26] The " lows " : Update on ER-low and HER2-low breast cancer
    Fusco, Nicola
    Viale, Giuseppe
    BREAST, 2024, 78
  • [27] Evaluation of HER2 scoring algorithms for identification of HER2-low breast cancer
    Costache, S.
    Nagy, A.
    Billingham, K.
    Haynes, H.
    Chefani, A.
    Thomas, T.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2020, 477 : S222 - S223
  • [28] Defining the patient population with HER2-low breast cancer in Hawaii
    Beaman, Amanda Yachiyo
    Hayama, Sara
    Pagano, Ian
    Killeen, Jeffrey
    Fukui, Jami Aya
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Characteristics and clinical outcomes of patients with HER2-low breast cancer
    Koh, S.
    Koi, Y.
    Tajiri, W.
    Kawasaki, J.
    Akiyoshi, S.
    Nakamura, Y.
    Koga, C.
    Tokunaga, E.
    BREAST, 2023, 68 : S32 - S32
  • [30] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Xin Yang
    Yao Li
    Xu lu
    Xiaotian Ren
    Bin Hua
    BMC Cancer, 23 (1)
12345